Abstract: A multi-state memory device includes a first memory element, a second memory element, a first controlling element and a second controlling element. The second memory element has a memory cell structure identical to that of the first memory element and connects to the first memory element in series. The first controlling element is connected to the first memory element either in series or in parallel. The second controlling element has a characteristic value identical to that of the first controlling element and is connected to the second memory element by a connection structure identical to that of the first controlling element. When the first memory element receives a first signal and a second signal through the first controlling element, a first state value and a second state value are generated correspondingly, and the characteristic value is greater than the first state value and less than the second state value.

Abstract: A method related to legalize mixed-cell height standard cells of an IC is provided. A global placement of the IC is obtained. A plurality of standard cells of the IC are placed in the global placement. Each standard cell is moved from a position to the nearest row in the global placement. A displacement value of each moved standard cell is obtained in the global placement. The global placement of the IC is divided into a plurality of windows according to the displacement values of the moved standard cells in each window and a dead space corresponding to each moved standard cell in each window. All overlapping areas among the standard cells of each window are removed to obtain a detailed placement. The IC is manufactured according to the detailed placement. The standard cells have different cell heights in each window.

Abstract: A method for legalizing mixed-cell height standard cells of an IC is provided. A target standard cell is obtained in a window of a global placement. The target standard cell has a first area overlapping a first standard cell located in a first row of the window, and a second area overlapping a second standard cell located in a second row of the window. The target standard cell and the first standard cell are moved until the target standard cell does not overlap the first standard cell in the first row of the window. The target standard cell and the first standard cell are clustered as a first cluster when the target standard cell does not overlap the first standard cell. The first cluster is moved away from the second standard cell in the second row until the second standard cell does not overlap the first cluster.

Abstract: A method for legalizing mixed-cell height standard cells of an IC is provided. A target standard cell is obtained in a window of a global placement. The target standard cell has a first area overlapping a first standard cell located in a first row of the window, and a second area overlapping a second standard cell located in a second row of the window. The target standard cell and the first standard cell are moved until the target standard cell does not overlap the first standard cell in the first row of the window. The target standard cell and the first standard cell are clustered as a first cluster when the target standard cell does not overlap the first standard cell. The first cluster is moved away from the second standard cell in the second row until the second standard cell does not overlap the first cluster.

Abstract: The present invention provides a method of digitizing nutritional status, muscle turnover, and risk assessment using the formulas containing four amino acids, which are Histidine, Leucine, Ornithine and Phenylalanine. The method of present invention can provide information regarding personalized nutritional status, muscle turnover and risk assessment, understand the effect of nutrition intervention, assist muscle growth and the effect of rehabilitation training, and improve patients' quality of life and bodily function.

Abstract: The disclosure provides a nutritional composition for improving a patient with heart failure; the nutritional composition is consisting of therapeutically effective high amounts of leucine and histidine. The disclosure also provides the nutritional supplement comprising the nutritional composition, which may be a beverage product, a dietary supplement or food. The disclosure further provides a method of using the nutritional supplement for treating patients with heart failure.

Abstract: An array password authentication method includes six authentication steps. The first authentication step is for inputting stored passwords into a system. The second authentication step is for displaying a plurality of first random codes arranged to form a first square matrix. One of the first random codes, is selected as a first inputting password. The third authentication step is for comparing the first stored password with the first inputting password. The fourth authentication step is for executing an anti-mistouch verification. The fifth authentication step is for displaying a plurality of second random codes arranged to form a second square matrix. One of the second random codes is selected as a second inputting password. The sixth authentication step is for comparing the second stored password with the second inputting password. If the second stored password and the second inputting password are different, the system is locked.

Abstract: The present invention provides a nutritional composition for improving a patient with heart failure; the nutritional composition is consisting of therapeutically effective high amounts of leucine and histidine. The present invention also provides the nutritional supplement comprising the nutritional composition, which may be a beverage product, a dietary supplement or food. The present invention further provides a method of using the nutritional supplement for treating patients with heart failure.

Abstract: A method for diagnosing heart failure in a subject is provided. The method includes steps of measuring a biological sample of the subject to obtain an amount of at least one biomarker selected from the group consisting of xanthine, spermidine, propionylcarnitine, butyrylcarnitine and P-cresyl sulfate; and comparing the amount of the at least one biomarker to a reference. Moreover, the present invention relates to a method for staging heart failure or evaluating a prognosis of heart failure in a subject.

Abstract: The present invention discloses a cell culturing formulation and a culturing and quantification method of CD140b+ cells thereof. The cell culturing formulation is applicable for inducing the growth of the CD140b+ cells in peripheral blood. The cell culturing formulation comprises a culturing medium, a serum, a mixed additive and a defined factor. Wherein, concentrations of the culturing medium, the serum, the mixed additive and the defined factor are 59˜98% (v/v), 0.1˜20% (v/v), 1˜10% (v/v) and 10?7˜10% (v/v) respectively.

Abstract: A laminate is provided for a transparent conductive film. The transparent conductive film includes a transparent substrate that has surfaces on which a laminate composed of multiple layers is formed. The laminate has a conductive layer that has an underside to which an underside coating layer made of silicon oxy-nitride is applied so as to make the transparent conductive film showing transparency in visible light and having a b* value of color coordinates between ?10?b*?2.5 and also reducing light reflection.

Abstract: A method for integrating enterprise collaborative operations in the product lifecycle management (PLM) and a system thereof are proposed. The system comprises at least a message server, at least a web server, a system engineering service platform server, at least a PLM application system server and an enterprise portal server. The system can build a system integration environment between customers, central manufacturers, and providers and offer a collaborative platform between enterprises. Information can thus be interchanged in real time in this system integration environment in the whole PLM from idea through specification requirement, design, development, manufacturing to termination, thereby providing a system integration method and environment for collaborative management, development, manufacturing and marketing between enterprises, providers and customers.